IDN vs IIIV vs TYRA vs AUID

For growth investors, authID Inc.

(AUID) is the stronger pick with 365. 9% revenue growth year-over-year, versus -100. 0% for Intellicheck, Inc. (IDN). i3 Verticals, Inc. (IIIV) offers the better valuation at 40. 9x trailing P/E (20. 3x forward), making it the more compelling value choice. Analysts rate Intellicheck, Inc. (IDN) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, i3 Verticals, Inc.

is actually cheaper at 20. 3x.

Over the past 5 years, Tyra Biosciences, Inc.

(TYRA) delivered a total return of +26. 5%, compared to -98. 4% for authID Inc. (AUID). Over 10 years, the gap is even starker: IDN returned +322. 3% versus AUID's -98. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Intellicheck, Inc.

(IDN) is the lower-risk stock at 0. 41β versus authID Inc. 's 1. 59β — meaning AUID is approximately 286% more volatile than IDN relative to the S&P 500. On balance sheet safety, i3 Verticals, Inc. (IIIV) carries a lower debt/equity ratio of 1% versus 2% for Tyra Biosciences, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), authID Inc.

(AUID) is pulling ahead at 365. 9% versus -100. 0% for Intellicheck, Inc. (IDN). On earnings-per-share growth, the picture is similar: Intellicheck, Inc. grew EPS 100. 0% year-over-year, compared to -87. 9% for i3 Verticals, Inc.. Over a 3-year CAGR, AUID leads at 13. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

i3 Verticals, Inc.

(IIIV) is the more profitable company, earning 8. 4% net margin versus -1610. 6% for authID Inc. — meaning it keeps 8. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IIIV leads at 1. 9% versus -1656. 5% for AUID. At the gross margin level — before operating expenses — AUID leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, i3 Verticals, Inc.

(IIIV) trades at 20. 3x forward P/E versus 75. 2x for Intellicheck, Inc. — 54. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TYRA: 53. 5% to $50. 50.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Intellicheck, Inc.

(IDN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 41), +322. 3% 10Y return). authID Inc. (AUID) carries a higher beta of 1. 59 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IDN: +322. 3%, AUID: -98. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (IDN (Technology) and IIIV (Technology) and TYRA (Healthcare) and AUID (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: IDN is a small-cap quality compounder stock; IIIV is a small-cap quality compounder stock; TYRA is a small-cap quality compounder stock; AUID is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.